经肝动脉化疗栓塞术治疗结直肠癌肝转移的研究进展

简乾洪; 郑方荣; 阎雄

doi:10.3969/j.issn.1001-5256.2016.06.047

经肝动脉化疗栓塞术治疗结直肠癌肝转移的研究进展

DOI: 10.3969/j.issn.1001-5256.2016.06.047

重庆医科大学附属第一医院肝胆外科

详细信息

中图分类号: R735.34
计量
- 文章访问数: 1567
- HTML全文浏览量: 40
- PDF下载量: 369
- 被引次数: 0
出版历程
- 出版日期: 2016-06-20

Current status of research on transcatheter arterial chemoembolization in treatment of colorectal cancer liver metastasis

摘要

摘要: 肝脏是公认的结直肠癌最普遍的转移器官,根治性切除术被认为是唯一可能治愈结直肠癌肝转移的治疗方案。但仅有约20%的患者能够接受手术治疗。对于已丧失手术机会的患者,经肝动脉化疗栓塞术(TACE)是被国内外学者广泛采用的首选治疗方案之一。介绍了现阶段临床上TACE治疗结直肠癌肝转移的应用基础、适应证、禁忌证、疗效、化疗药物及栓塞剂等。认为TACE是一种疗效肯定、微创、副反应少的姑息性治疗方案,可以作为不可切除结直肠癌肝转移患者的首选治疗方案。
- 结直肠肿瘤 /
- 肿瘤转移 /
- 化学栓塞,治疗性 /
- 综述
Abstract: It is widely acknowledged that the liver is the most common organ for colorectal cancer metastasis,and radical resection is thought to be the only therapeutic method to cure colorectal cancer liver metastasis(CRLM).Unfortunately,only about 20% of all patients are eligible for surgical resection.In patients who cannot be treated with surgery,transcatheter arterial chemoembolization(TACE) has been widely used as the preferred therapeutic method by scholars at home and abroad.This article introduces the application basis,indications,contraindications,therapeutic effect,chemotherapeutic agents,and embolic agents of TACE in the treatment of CRLM,and points out that TACE is a palliative treatment regimen with a clear therapeutic effect,minimal invasion,and few side effects and can be used as the preferred therapeutic regimen for patients with unresectable CRLM.
- colorectal neoplasm /
- neoplasm metastasis /
- chemoembolization /
- therapeutic

HTML全文

参考文献(34)

[1]TORRE LA,BRAY F,SIEGEL RL,et al.Global cancer statistics2012[J].CA Cancer J Clin,2015,65(2):87-108.

[2]SLESSER A,GEORGIOU P,BROWN G,et al.The tumour biology of synchronous and metachronous colorectal liver metastases:a systematic review[J].Clin Exp Metastasis,2013,30(4):457-470.

[3]MA KS,ZHANG ZB.Surgical strategies for colorectal liver metastases in different stages[J].Chin J Dig Surg,2014,13(3):165-167.(in Chinese)马宽生,张哲菠.不同阶段结直肠癌肝转移的手术策略[J].中华消化外科杂志,2014,13(3):165-167.

[4] ITO K,GOVINDARAJAN A,ITO H,et al.Surgical treatment of hepatic colorectal metastasis:evolving role in the setting of improving systemic therapies and ablative treatments in the 21st century[J].Cancer J,2010,16(2):103-110.

[5]HEINRICH S,LANG H.Liver metastases from colorectal cancer:technique of liver resection[J].J Surg Oncol,2013,107(6):579-584.

[6] KASSAHUN WT.Unresolved issues and controversies surrounding the management of colorectal cancer liver metastasis[J].World JSurg Oncol,2015,13(1):61.

[7]LI ZG,HUANG JX,LI SZ,et al.Blood supply of liver metastasis[J].J Peking Univ:Health Sci,2008,40(1):146-150.(in Chinese)李智岗,黄景香,李顺宗,等.肝转移瘤的血供[J].北京大学学报:医学版,2008,40(1):146-150.

[8]DEZSK,BUGYIK E,PAPP V,et al.Development of arterial blood supply in experimental liver metastases[J].Am J Pathol,2009,175(2):835-843.

[9]WU ZL,WU YC,GU TS,et al.Analysis on blood supply of metastasis liver neoplasm[J].J Hebei Med Univ,2015,36(4):428-432.(in Chinese)武中林,吴勇超,谷铁树,等.肝转移瘤血液供应来源分析[J].河北医科大学学报,2015,36(4):428-432.

[10]HAN GH,TIE J.Interventional treatment of liver metastases[J].Chin J Dig Surg,2014,13(3):171-174.(in Chinese)韩国宏,帖君.转移性肝癌的介入治疗[J].中华消化外科杂志,2014,13(3):171-174.

[11]JIANG HZ,DENG X.TACE treatment for liver cancer with portal vein tumor thrombus[J].Chin J Gen Surg,2015,24(1):116-120.(in Chinese)江海中,邓新.肝癌合并门静脉癌栓的TACE治疗[J].中华普通外科杂志,2015,24(1):116-120.

[12]SCHULTHEISS M,MARUSCHKE L.How to do:transarterial chemoembolization(TACE)[J].Dtsch Med Wochenschr,2015,140(6):418-421.

[13] MASSMANN A,RODT T,MARQUARDT S,et al.Transarterial chemoembolization(TACE)for colorectal liver metastases-current status and critical review[J].Langenbecks Arch Surg,2015,400(6):641-659.

[14] LUO J,GUO RP,LAI EC,et al.Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis:a prospective comparative study[J].Ann Surg Oncol,2011,18(2):413-420.

[15] YANG HJ,LEE JH,LEE DH,et al.Small single-nodule hepatocellular carcinoma:comparison of transarterial chemoembolization,radiofrequency ablation,and hepatic resection by using inverse probability weighting[J].Radiology,2014,271(3):909-918.

[16]HAN X.Clinical analysis of metastatic liver cancer cases with transcatheter arterial chemoembolization[D].Anhui:Anhui Med Univ,2013.(in Chinese)含笑.肝转移癌TACE疗效评价及影响因素分析[D].安徽:安徽医科大学,2013.

[17] HASHIMOTO Y,SASAKI Y,YOKOYAMA S,et al.A long-term survivor of a rectal carcinoid treated by use of repeat TACE for multiple intrahepatic recurrences after liver resection and MCT[J].Gan To Kagaku Ryoho,2014,41(12):2142-2144.

[18] SUCIU B,GURZU S,MARGINEAN L,et al.Significant shrinkage of multifocal liver metastases and long-term survival in a patient with rectal cancer,after trans-arterial chemoembolization(TACE)[J].Medicine,2015,94(42):e1848.

[19]HUPPERT P,WENZEL T,WIETHOLTZ H.Transcatheter arterial chemoembolization(TACE)of colorectal cancer liver metastases by irinotecan-eluting microspheres in a salvage patient population[J].Cardiovasc Intervent Radiol,2014,37(1):154-164.

[20]STUTZ M,MAMO A,VALENTI D,et al.Real-life report on chemoembolization using DEBIRI for liver metastases from colorectal cancer[J].Gastroenterol Res Pract,2015,3(8):1675-1687.

[21]KHOURI C,GUIU B,CERCUEIL J,et al.Raltitrexed and oxaliplatin hepatic arterial infusion for advanced colorectal cancer:a retrospective study[J].Anti-Cancer Drugs,2010,21(6):656-661.

[22]KELLY C,BHUVA N,HARRISON M,et al.Use of raltitrexed as an alternative to 5-fluorouracil and capecitabine in cancer patients with cardiac history[J].Eur J Cancer,2013,49(10):2303-2310.

[23]AVALLONE A,DI GENNARO E,SILVESTRO L,et al.Targeting thymidylate synthase in colorectal cancer:critical re-evaluation and emerging therapeutic role of raltitrexed[J].Expert Opin Drug Saf,2014,13(1):113-129.

[24] BARNI S,GHIDINI A,COINU A,et al.A systematic review of raltitrexed-based first-line chemotherapy in advanced colorectal cancer[J].Anti-Cancer Drugs,2014,25(10):1122-1128.

[25] SCHMOLL H,van CUTSEM E,STEIN A,et al.ESMO Consensus Guidelines for management of patients with colon and rectal cancer.A personalized approach to clinical decision making[J].Ann Oncol,2012,23(10):2479-2516.

[26]Bureau of Medical Administration,National Health Oncology Branch of Chinese Medical Association.Standardization of diagnosis and treatment for colorectal cancer in China(2015 edition)[J].Chin JDigest Surg,2015,14(10):783-799.(in Chinese)中华人民共和国卫生和计划生育委员会医政医管局与中华医学会肿瘤学分会.中国结直肠癌诊疗规范(2015版)[J].中华消化外科杂志,2015,14(10):783-799.

[27]BROWN D,PILGRAM T,DARCY M,et al.Hepatic arterial chemoembolization for hepatocellular carcinoma:comparison of survival rates with different embolic agents[J].J Vasc Interv Radiol,2005,16(12):1661-1666.

[28]SCAFFARO LA,KRUEL CD,STELLA SF,et al.Transarterial embolization for hepatocellular carcinoma:a comparison between nonspherical PVA and microspheres[J].Biomed Res Int,2015,2015(4):1-5.

[29]CAI L,LI XW,XIA F,et al.Clinical efficacy of radiofrequency ablation for the treatment of metastatic hepatic carcinoma[J].Chin J Dig Surg,2014,13(3):190-193.(in Chinese)蔡磊,李晓武,夏锋,等.射频消融治疗转移性肝癌的临床疗效[J].中华消化外科杂志,2014,13(3):190-193.

[30] TANIS E,NORDLINGER B,MAUER M,et al.Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases.Analysis of the European Organisation for Research and Treatment of Cancer#40004 and#40983[J].Eur J Cancer,2014,50(5):912-919.

[31] FONG ZV,PALAZZO F,NEEDLEMAN L,et al.Combined hepatic arterial embolization and hepatic ablation for unresectable colorectal metastases to the liver[J].Am Surg,2012,78(11):1243-1248.

[32]BESTER L,METELING B,POCOCK N,et al.Radioembolisation with Yttrium-90 microspheres:an effective treatment modality for unresectable liver metastases[J].J Med Imaging Radiat Oncol,2013,57(1):72-80.

[33] GOLFIERI R,MOSCONI C,GIAMPALMA E,et al.Selective transarterial radioembolisation of unresectable liver-dominant colorectal cancer refractory to chemotherapy[J].Radiol Med,2015,120(8):767-776.

[34]LI HT,CHEN C,ZHANG HY,et al.Efficacy and safety of spleen-strengthening and stasis-resolving prescription combined with interventional operation in treatment of patients with recurrence of liver cancer after liver transplantation[J].Chin J Clin Ration Drug Use,2015,8(10A):39-40.(in Chinese)李海涛,陈超,张红玉,等.健脾化瘀方联合介入手术治疗肝癌肝移植复发患者的疗效及安全性分析[J].临床合理用药杂志,2015,8(10A):39-40.

施引文献

资源附件(0)

访问统计